Last updated: 21 November 2022 at 10:58pm EST

Steven H Azurite Management... Net Worth




The estimated Net Worth of Steven H Azurite Management... is at least 2.55 百万$ dollars as of 17 November 2022. Steven Management owns over 122,820 units of Invacare stock worth over 2,419,054$ and over the last 2 years Steven sold IVC stock worth over 127,152$.

Steven Management IVC stock SEC Form 4 insiders trading

Steven has made over 3 trades of the Invacare stock since 2022, according to the Form 4 filled with the SEC. Most recently Steven sold 122,820 units of IVC stock worth 47,900$ on 17 November 2022.

The largest trade Steven's ever made was selling 158,505 units of Invacare stock on 14 November 2022 worth over 79,253$. On average, Steven trades about 143,775 units every 50 days since 2022. As of 17 November 2022 Steven still owns at least 3,665,233 units of Invacare stock.

You can see the complete history of Steven Management stock trades at the bottom of the page.



Insiders trading at Invacare

Over the last 21 years, insiders at Invacare have traded over 3,551,958$ worth of Invacare stock and bought 391,450 units worth 2,325,949$ . The most active insiders traders include Edward F CrawfordAaron Malachi Iii MixonSteven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of 10,700$. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth 47,900$.



What does Invacare do?

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.



Complete history of Steven Management stock trades at Invacare

インサイダー
取引
取引
合計金額
Steven H Azurite Management...
販売 47,900$
17 Nov 2022
Steven H Azurite Management...
販売 79,253$
14 Nov 2022
Steven H Azurite Management...
購入する 219,000$
21 Jun 2022


Invacare executives and stock owners

Invacare executives and other stock owners filed with the SEC include: